Molecular master switch for pancreatic cancer identified, potential predictor of treatment outcome
Tuesday, February 12, 2013 - 15:00
in Health & Medicine
A recently described master regulator protein may explain the development of aberrant cell growth in the pancreas spurred by inflammation. The team profiled gene expression of mouse pancreatic ductal and duct-like cells from different states -- embryonic development, acute pancreatitis and K-ras mutation-driven carcinogenesis -- to find the molecular regulation of these processes.